Tirzepatide has not been shown to cause cancer in people, but it carries a boxed warning about thyroid C-cell tumors seen in rats. The label says it is unknown whether the same thing happens in humans. Because of that warning, the drug must not be used by anyone with a personal or family history of medullary thyroid cancer or MEN 2. The label lists no other cancer risk. Start with our tirzepatide guide if you are new to the drug.
Key takeaways
- The only cancer warning on the Zepbound and Mounjaro labels is the boxed warning for thyroid C-cell tumors. It is based on rat studies.
- The label says it is unknown whether tirzepatide causes these tumors in people.
- Do not take tirzepatide if you or a blood relative has had medullary thyroid cancer (MTC), or if you have MEN 2.
- Report a neck lump, trouble swallowing, a hoarse voice or shortness of breath to your prescriber.
- The label does not list breast, colon, pancreatic or any other cancer as a risk.
Tirzepatide thyroid cancer: the boxed warning, as the label frames it
A boxed warning is the strongest warning the FDA puts on a drug label. For tirzepatide, it is about thyroid C-cell tumors. The wording matters, so here is the substance of it, piece by piece.
| What the label says | Plain English |
|---|---|
| Tirzepatide causes thyroid C-cell tumors in rats | Rats given the drug grew tumors in the C-cells of the thyroid |
| It is unknown whether tirzepatide causes thyroid C-cell tumors, including MTC, in humans | No one has shown this happens in people. No one has ruled it out either. |
| Contraindicated with a personal or family history of MTC, or with MEN 2 | If you or a blood relative has had MTC, or you have MEN 2, do not take it |
| Counsel patients on the potential risk and the symptoms of thyroid tumors | Your prescriber should tell you about this warning and what to watch for |
| Routine calcitonin blood tests or thyroid ultrasound are of uncertain value | The label does not call for regular tests or scans for this warning |
Source: Zepbound and Mounjaro labels, Boxed Warning, Contraindications, and Warnings and Precautions sections (DailyMed).
Two points are easy to miss. First, the rat finding is a class effect. Drugs that act on the GLP-1 receptor share it, which is why the same boxed warning sits on similar drugs. Second, the label says the human relevance is unknown. It does not say the risk is zero. It does not say the risk is proven.
Does tirzepatide cause thyroid cancer in humans?
The label's answer is "unknown." The SURMOUNT and SURPASS trials enrolled thousands of adults. They kept out people with a personal or family history of MTC or MEN 2. They were not built to find a rare cancer over a few years. So the trials cannot prove safety on this point. They did not show a signal either. That is the honest state of the evidence: an animal finding, a human question mark, and a label written to keep the highest-risk people off the drug.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Symptoms to report
The label asks prescribers to tell every patient the signs of a thyroid tumor. These are the four to remember.
| Symptom | What to do |
|---|---|
| A lump or swelling in the neck | Contact your prescriber. Do not wait for the next visit. |
| Trouble swallowing | Contact your prescriber |
| A hoarse voice that does not go away | Contact your prescriber |
| Shortness of breath | Contact your prescriber. Seek urgent care if it is sudden or severe. |
Source: Zepbound label, Patient Counseling Information and Medication Guide (DailyMed).
Tirzepatide and thyroid nodules
Thyroid nodules are common, and most are harmless. The label does not talk about nodules directly. It bars the drug for MTC and MEN 2, and it says routine calcitonin tests or scans are of uncertain value. If you already have a nodule, or one is found while you are on the drug, tell both prescribers: the one who manages the nodule and the one who writes for tirzepatide. Whether to continue is their call, made with your history in front of them. No label can give that answer on its own.
Does tirzepatide cause any other cancer?
No. Not according to the label. No other cancer appears in the Warnings and Precautions section of either label. The label does not list breast cancer, colon cancer, pancreatic cancer or any other tumor as a risk. Pancreatitis, which is an inflamed pancreas, is a separate label warning. It is not the same as pancreatic cancer. If you read that tirzepatide causes a cancer other than the thyroid C-cell finding, that claim is not coming from the label.
About the video: "Can cause thyroid cancer!"
A widely shared video is titled "Semaglutide (Ozempic), Tirzepatide (Mounjaro) Can Cause Thyroid Cancer!" That title is a claim. This page checks it against the label. The label supports part of it. These drugs did cause thyroid C-cell tumors in rats, and the FDA took that seriously enough to require a boxed warning. The label does not support the rest. There is no proven link to thyroid cancer in people. The accurate sentence is "may cause thyroid C-cell tumors; human relevance unknown." It is less dramatic and more correct.
What this means for compounded tirzepatide
Compounded tirzepatide contains the same active molecule. The same boxed warning and the same MTC and MEN 2 rule apply. It is not FDA approved and is not interchangeable with Zepbound or Mounjaro. Any assessment for compounded tirzepatide should ask about your personal and family thyroid history. The FormBlends assessment does. The independent clinicians of Recess MD LLC will not prescribe if that history rules it out, and if the provider does not prescribe, the charge is refunded. You can start the assessment when you are ready.
Frequently Asked Questions
Does tirzepatide cause cancer?
Not that anyone has shown in people. The Zepbound and Mounjaro labels carry one cancer warning, for thyroid C-cell tumors seen in rats. The label says the human relevance is unknown. No other cancer is listed as a risk.
What are tirzepatide side effects related to cancer?
The label does not list any cancer as an adverse reaction. The boxed warning describes a possible risk of thyroid C-cell tumors. The signs to report are a neck lump, trouble swallowing, a hoarse voice and shortness of breath. The common side effects are gut symptoms like nausea and diarrhea.
What is the Zepbound thyroid cancer risk?
Zepbound's boxed warning says the drug caused thyroid C-cell tumors in rats. It says it is unknown whether it does so in humans. The drug must not be used with a personal or family history of MTC or with MEN 2. The label says routine calcitonin tests or ultrasounds are of uncertain value.
Can I take tirzepatide if I have thyroid nodules?
The label does not address nodules directly. It bars the drug for MTC and MEN 2 history. Tell both the prescriber who manages the nodule and the prescriber for tirzepatide. They decide together based on your history.
Does tirzepatide cause thyroid cancer if I take it for years?
The longest controlled data run about three years, from the SURMOUNT-1 extension. Those trials kept out people at highest thyroid risk. They showed no signal, but they were not built to settle a rare cancer question. The label's "unknown" stands no matter how long you take it.
Sources
- Zepbound (tirzepatide) prescribing information, DailyMed, Eli Lilly, revised 08/2026.
- Mounjaro (tirzepatide) prescribing information, DailyMed, Eli Lilly, revised 08/2026.
- Mounjaro U.S. prescribing information (PDF), Eli Lilly, revised 08/2026.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
- Tirzepatide for Obesity Treatment and Diabetes Prevention (SURMOUNT-1 three-year extension), Jastreboff et al., New England Journal of Medicine, 2025.
Next steps
See the complete tirzepatide side effects guide for every label warning, and our page on tirzepatide drug interactions. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician about your thyroid history before you start. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →